🏛️ Verified NIH Record • Updated 2025-07-28
PET Detection of CCR2 in Human Atherosclerosis (NCT04537403)
🟢 Recruiting Phase1 💊 Investigational Drug / Biologic Sponsor: Washington University School of Medicine
🩺 Plain-English Summary (8th-Grade Level)
: Use of novel radio-pharmaceutical 64CUDOTA-ECL1i to evaluate arterial atherosclrosis
Who can join: Review the eligibility criteria below.
Location: Washington University CCIR — St Louis, Missouri
Age range: 18 Years to 89 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Washington University CCIR — St Louis, Missouri
📞 Contact the Study Coordinator
Phone: (314) 747-0183
Email: harrisonk@mir.wustl.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Carotid Atherosclerosis
- CANF-Comb-II PET-MR in Atherosclerosis Multisite — Los Angeles, California
Explore by condition: All Carotid Atherosclerosis clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.